ArticleACS omega2020
Design and Synthesis of a New Class of Pyridine-Based
Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Synthetic strategies towards benzothiazole-based compounds of therapeutic potency: experimental, investigational and approved drugs.RSC advances · 2025Review
- Novel 2-substituted benzothiazole derivatives: synthesis,RSC advances · 2025Article
- Crystal structure of the 1:1 adduct of (Acta crystallographica. Section E, Crystallographic communications · 2025Article
- Crystal structure of 1-amino-3-(4-chloro-phen-yl)-2-cyano-3Acta crystallographica. Section E, Crystallographic communications · 2025Article
- The Structure-Antiproliferative Activity Relationship of Pyridine Derivatives.International journal of molecular sciences · 2024Review
- Synthesis and Biological Evaluation of Benzothiazolyl-pyridine Hybrids as New Antiviral Agents against H5N1 Bird Flu and SARS-COV-2 Viruses.ACS omega · 2023Article
- Crystal structure of 2-{[5-(methyl-sulfan-yl)-4-phenyl-4Acta crystallographica. Section E, Crystallographic communications · 2023Article
- Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes.Pharmaceuticals (Basel, Switzerland) · 2023Article
- Article
- Crystal structure ofActa crystallographica. Section E, Crystallographic communications · 2023Article
- Crystal structures of three homologues with increasing ring size: 2-meth-oxy-4-(thio-phen-2-yl)-5,6,7,8-tetra-hydro-quinoline-3-carbo-nitrile, 2-meth-oxy-4-(thio-phen-2-yl)-6,7,8,9-tetra-hydro-5Acta crystallographica. Section E, Crystallographic communications · 2023Article
- Recent Advances in Pyridine Scaffold: Focus on Chemistry, Synthesis, and Antibacterial Activities.BioMed research international · 2023Review
- Sulfonamides with Heterocyclic Periphery as Antiviral Agents.Molecules (Basel, Switzerland) · 2022Review
- Synthesis, Physicochemical Properties and Molecular Docking of New Benzothiazole Derivatives as Antimicrobial Agents Targeting DHPS Enzyme.Antibiotics (Basel, Switzerland) · 2022Article
- Article
- Crystal structure of 2-(benzo[Acta crystallographica. Section E, Crystallographic communications · 2022Article
- 4-Amino-5-(4-bromo-benzo-yl)-3-(benzo[IUCrData · 2022Article
- Crystal structure of 2-(2,5-di-meth-oxy-phen-yl)benzo[Acta crystallographica. Section E, Crystallographic communications · 2022Article
- 3-(Benzo[IUCrData · 2022Article
- Crystal structure ofActa crystallographica. Section E, Crystallographic communications · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A new strategy for designing and assembling a novel class of functionalized pyridine-based benzothiazole and benzimidazole incorporating sulfonamide moieties was developed. The synthesis was carried out by reacting
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.